Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nigel Curtis

Showing results (341-350 of 377) with videos related to

Pageof 38
Sort By:
Allergy|July 26, 2021
Prevention of infant eczema by neonatal Bacillus Calmette-Guérin vaccination: The MIS BAIR randomized controlled trialLaure F Pittet, Nicole L Messina, Kaya Gardiner, et al.
Human Vaccines & Immunotherapeutics|August 8, 2023
Safety of BCG vaccination and revaccination in healthcare workersPaola Villanueva, Nigel W Crawford, Mariana Garcia Croda, et al.
Heliyon|July 19, 2024
Accelerated Bacille Calmette-Guérin reactions: More than meets the eyePaola Villanueva, Nigel W Crawford, Mariana Garcia Croda, et al.
BMJ Open|December 18, 2019
Study protocol for the Melbourne Infant Study: BCG for Allergy and Infection Reduction (MIS BAIR), a randomised controlled trial to determine the non-specific effects of neonatal BCG vaccination in a low-mortality settingNicole L Messina, Kaya Gardiner, Susan Donath, et al.
The Journal of Infectious Diseases|June 19, 2021
Neonatal Bacille Calmette-Guérin Vaccination and Infections in the First Year of Life: The MIS BAIR Randomized Controlled TrialNicole L Messina, Laure F Pittet, Kaya Gardiner, et al.
Science Advances|August 5, 2022
Neonatal BCG vaccination is associated with a long-term DNA methylation signature in circulating monocytesSamantha Bannister, Bowon Kim, Jorge Domínguez-Andrés, et al.
Plos Medicine|June 10, 2024
Immunogenicity, reactogenicity, and IgE-mediated immune responses of a mixed whole-cell and acellular pertussis vaccine schedule in Australian infants: A randomised, double-blind, noninferiority trialGladymar Pérez Chacón, Marie J Estcourt, James Totterdell, et al.
The Journal of Infection|May 25, 2025
Immune impacts of infant whole-cell and acellular pertussis vaccination on co-administered vaccinesGladymar Pérez Chacón, Sonia McAlister, James Totterdell, et al.
The Lancet. Infectious Diseases|June 10, 2018
Treatment and secondary prophylaxis with ethanol lock therapy for central line-associated bloodstream infection in paediatric cancer: a randomised, double-blind, controlled trialJoshua Wolf, Tom G Connell, Kim J Allison, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 14, 2024
Neonatal BCG Vaccination for Prevention of Allergy in Infants: The MIS BAIR Randomised Controlled TrialNicole L Messina, Kaya Gardiner, Laure F Pittet, et al.
Pageof 38

Showing results (341-350 of 377) with videos related to

Sort By:
Pageof 38
Allergy|July 26, 2021
Prevention of infant eczema by neonatal Bacillus Calmette-Guérin vaccination: The MIS BAIR randomized controlled trialLaure F Pittet, Nicole L Messina, Kaya Gardiner, et al.
Human Vaccines & Immunotherapeutics|August 8, 2023
Safety of BCG vaccination and revaccination in healthcare workersPaola Villanueva, Nigel W Crawford, Mariana Garcia Croda, et al.
Heliyon|July 19, 2024
Accelerated Bacille Calmette-Guérin reactions: More than meets the eyePaola Villanueva, Nigel W Crawford, Mariana Garcia Croda, et al.
BMJ Open|December 18, 2019
Study protocol for the Melbourne Infant Study: BCG for Allergy and Infection Reduction (MIS BAIR), a randomised controlled trial to determine the non-specific effects of neonatal BCG vaccination in a low-mortality settingNicole L Messina, Kaya Gardiner, Susan Donath, et al.
The Journal of Infectious Diseases|June 19, 2021
Neonatal Bacille Calmette-Guérin Vaccination and Infections in the First Year of Life: The MIS BAIR Randomized Controlled TrialNicole L Messina, Laure F Pittet, Kaya Gardiner, et al.
Science Advances|August 5, 2022
Neonatal BCG vaccination is associated with a long-term DNA methylation signature in circulating monocytesSamantha Bannister, Bowon Kim, Jorge Domínguez-Andrés, et al.
Plos Medicine|June 10, 2024
Immunogenicity, reactogenicity, and IgE-mediated immune responses of a mixed whole-cell and acellular pertussis vaccine schedule in Australian infants: A randomised, double-blind, noninferiority trialGladymar Pérez Chacón, Marie J Estcourt, James Totterdell, et al.
The Journal of Infection|May 25, 2025
Immune impacts of infant whole-cell and acellular pertussis vaccination on co-administered vaccinesGladymar Pérez Chacón, Sonia McAlister, James Totterdell, et al.
The Lancet. Infectious Diseases|June 10, 2018
Treatment and secondary prophylaxis with ethanol lock therapy for central line-associated bloodstream infection in paediatric cancer: a randomised, double-blind, controlled trialJoshua Wolf, Tom G Connell, Kim J Allison, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 14, 2024
Neonatal BCG Vaccination for Prevention of Allergy in Infants: The MIS BAIR Randomised Controlled TrialNicole L Messina, Kaya Gardiner, Laure F Pittet, et al.
Pageof 38